Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincenzo Solfrizzi

Showing results (11-20 of 264) with videos related to

Pageof 27
Sort By:
Frontiers in Aging Neuroscience|August 21, 2010
Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment?Bruno P Imbimbo, Vincenzo Solfrizzi, Francesco Panza
Handbook of Clinical Neurology|August 24, 2023
Passive tau-based immunotherapy for tauopathiesFrancesco Panza, Vincenzo Solfrizzi, Antonio Daniele, et al.
Nature Aging|October 17, 2025
Embedding oral health indicators into multidimensional frailty modelsVittorio Dibello, Frank Lobbezoo, Vincenzo Solfrizzi, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|August 13, 2021
When Inappropriate Use of Insulin is Dangerous: The Utility of C-Peptide Assay in the Era of Cardioprotective Antidiabetic DrugsSara Volpe, Cosimo Tortorella, Vincenzo Solfrizzi, et al.
Expert Opinion on Biological Therapy|July 2, 2014
Amyloid-directed monoclonal antibodies for the treatment of Alzheimer's disease: the point of no return?Francesco Panza, Vincenzo Solfrizzi, Bruno P Imbimbo, et al.
Brain Research Bulletin|February 9, 2006
Nutritional factors, cognitive decline, and dementiaAngelo Del Parigi, Francesco Panza, Cristiano Capurso, et al.
Current Opinion in Psychiatry|January 22, 2014
Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?Francesco Panza, Giancarlo Logroscino, Bruno P Imbimbo, et al.
Lancet (London, England)|February 3, 2009
N-3 polyunsaturated fatty acids and statins in heart failureVincenzo Solfrizzi, Cristiano Capurso, Gianluigi Vendemiale, et al.
Journal of the American Geriatrics Society|December 15, 2010
Plasma lipid disturbances and cognitive declineVincenza Frisardi, Francesco Panza, Vincenzo Solfrizzi, et al.
Journal of the American Geriatrics Society|November 9, 2010
Plasma levels of n-3 polyunsaturated fatty acids and cognitive decline: possible role of depressive symptoms and apolipoprotein E genotypingFrancesco Panza, Vincenza Frisardi, Davide Seripa, et al.
Pageof 27

Showing results (11-20 of 264) with videos related to

Sort By:
Pageof 27
Frontiers in Aging Neuroscience|August 21, 2010
Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment?Bruno P Imbimbo, Vincenzo Solfrizzi, Francesco Panza
Handbook of Clinical Neurology|August 24, 2023
Passive tau-based immunotherapy for tauopathiesFrancesco Panza, Vincenzo Solfrizzi, Antonio Daniele, et al.
Nature Aging|October 17, 2025
Embedding oral health indicators into multidimensional frailty modelsVittorio Dibello, Frank Lobbezoo, Vincenzo Solfrizzi, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|August 13, 2021
When Inappropriate Use of Insulin is Dangerous: The Utility of C-Peptide Assay in the Era of Cardioprotective Antidiabetic DrugsSara Volpe, Cosimo Tortorella, Vincenzo Solfrizzi, et al.
Expert Opinion on Biological Therapy|July 2, 2014
Amyloid-directed monoclonal antibodies for the treatment of Alzheimer's disease: the point of no return?Francesco Panza, Vincenzo Solfrizzi, Bruno P Imbimbo, et al.
Brain Research Bulletin|February 9, 2006
Nutritional factors, cognitive decline, and dementiaAngelo Del Parigi, Francesco Panza, Cristiano Capurso, et al.
Current Opinion in Psychiatry|January 22, 2014
Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?Francesco Panza, Giancarlo Logroscino, Bruno P Imbimbo, et al.
Lancet (London, England)|February 3, 2009
N-3 polyunsaturated fatty acids and statins in heart failureVincenzo Solfrizzi, Cristiano Capurso, Gianluigi Vendemiale, et al.
Journal of the American Geriatrics Society|December 15, 2010
Plasma lipid disturbances and cognitive declineVincenza Frisardi, Francesco Panza, Vincenzo Solfrizzi, et al.
Journal of the American Geriatrics Society|November 9, 2010
Plasma levels of n-3 polyunsaturated fatty acids and cognitive decline: possible role of depressive symptoms and apolipoprotein E genotypingFrancesco Panza, Vincenza Frisardi, Davide Seripa, et al.
Pageof 27